Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach
| Project/Area Number |
21390231
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (B)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Sapporo Medical University |
|---|
Principal Investigator |
KATO Junji 札幌医科大学, 医学部, 教授 (20244345)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
TAKIMOTO Rishu 札幌医科大学, 医学部, 講師 (10336399)
KOBUNE Masayoshi 札幌医科大学, 医学部, 准教授 (90336389)
|
|---|
| Project Period (FY) |
2009 – 2011
|
| Project Status |
Completed (Fiscal Year 2011)
|
| Budget Amount *help |
¥17,810,000 (Direct Cost: ¥13,700,000、Indirect Cost: ¥4,110,000)
Fiscal Year 2011: ¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2010: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Fiscal Year 2009: ¥8,190,000 (Direct Cost: ¥6,300,000、Indirect Cost: ¥1,890,000)
|
|---|
| Keywords | 癌 / 糖鎖 / 内科 / (1)癌 / (2)糖鎖 |
|---|
| Research Abstract |
Owing to its aggressiveness and the lack of effective therapies, pancreatic ductal adenocarcinoma has a dismal prognosis. New strategies to improve treatment and survival are therefore urgently required. We developed X-bound nanoparticles as vehicles for delivery of anticancer drugs specifically to cancer cells. X-bound liposomes containing Cy5. 5 or Cisplatin were effectively delivered into CA19-9 expressing pancreatic cancer cells. Intravenously injected X-bound liposomes carrying Cisplatin were successfully delivered to pancreatic cancer cells, mediating efficient tumor growth inhibition as well as prolonging survival in mouse xenograft models. This modality represents a new strategy for pancreatic cancer cell-targeting therapy.
|
Report
(4 results)
Research Products
(16 results)
